NaCl induced high cationic hydroxyethylated cholesterol-based nanoparticle-mediated synthetic small interfering RNA transfer into prostate carcinoma PC-3 cells

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 12, 2008, Pages 2294-2301

  Hattori, Yoshiyuki ^a   Yoshizawa, Takashi ^a   Koga, Kimiko ^a   Maitani, Yoshie ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Cationic nanoparticle; Cholesteryl 3 carboxyamidoethylene N hydroxyethylamine; Nanoplex; PC 3 cell; RNA delivery; Synthetic small interfering RNA

Indexed keywords

CHOLESTEROL DERIVATIVE; CHOLESTERYL 3BETA CARBOXYAMIDOETHYLENE N HYDROXYETHYLAMINE; NANOPARTICLE; PLASMID DNA; POLYSORBATE 80; PROTEIN BCL 2; SMALL INTERFERING RNA; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; RNA INTERFERENCE;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLESTEROL; DNA, NEOPLASM; ELECTROCHEMISTRY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLOW CYTOMETRY; GENES, BCL-2; GENETIC VECTORS; HUMANS; LUCIFERASES; MICROSCOPY, CONFOCAL; NANOPARTICLES; PLASMIDS; POLYSORBATES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SODIUM CHLORIDE; SURFACE-ACTIVE AGENTS; TRANSFECTION;

EID: 57349096726     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.2294     Document Type: Article

References (31)

1. Pai S. I., Lin Y. Y., Macaes B., Meneshian A., Hung C. F., Wu T. C., Gene Ther., 13, 464-477 (2006).
2. Kim D. H., Behlke M. A., Rose S. D., Chang M. S., Choi S., Rossi J. J., Nat. Biotechnol., 23, 222-226 (2005).
3. McManus M. T., Sharp P. A., Nat. Rev. Genet., 3, 737-747 (2002).
4. Scherr M., Morgan M. A., Eder M., Curr. Med. Chem., 10, 245-256 (2003).
5. Brummelkamp T. R., Bernards R., Agami R., Cancer Cell, 2, 243-247 (2002).
6. Lois C., Refaeli Y., Qin X. F., Van Parijs L., Curr. Opin. Immunol., 13, 496-504 (2001).
7. Lu S., Cullen B. R., J. Virol., 78, 12868-12876 (2004).
8. Uchida H., Tanaka T., Sasaki K., Kato K., Dehari H., Ito Y., Kobune M., Miyagishi M., Taira K., Tahara H., Hamada H., Mol. Ther., 10, 162-171 (2004).
9. Arts G. J., Langemeijer E., Tissingh R., Ma L., Pavliska H., Dokic K., Dooijes R., Mesic E., Clasen R., Michiels F., van der S. J., Lambrecht M., Herman S., Brys R., Thys K., Hoffmann M., Tomme P., van E. H., Genome Res., 13, 2325-2332 (2003).
10. Abbas-Terki T., Blanco-Bose W., Deglon N., Pralong W., Aebischer P., Hum. Gene Ther., 13, 2197-2201 (2002).
11. Dirac A. M., Bernards R., J. Biol. Chem., 278, 11731-11734 (2003).
12. Rubinson D. A., Dillon C. P., Kwiatkowski A. V., Sievers C., Yang L., Kopinja J., Rooney D. L., Ihrig M. M., McManus M. T., Gertler F. B., Scott M. L., Van Parijs L., Nat. Genet., 33, 401-406 (2003).
13. Spagnou S., Miller A. D., Keller M., Biochemistry, 43, 13348-13356 (2004).
14. Hasegawa S., Hirashima N., Nakanishi M., Bioorg. Med. Chem. Lett., 12, 1299-1302 (2002).
15. Nakanishi M., Curr. Med. Chem., 10, 1289-1296 (2003).
16. Percot A., Briane D., Coudert R., Reynier P., Bouchemal N., Lievre N., Hantz E., Salzmann J. L., Cao A., Int. J. Pharm., 278, 143-163 (2004).
17. Okayama R., Noji M., Nakanishi M., FEBS Lett., 408, 232-234 (1997).
18. Noguchi S., Hirashima N., Furuno T., Nakanishi M., J. Controlled Release, 88, 313-320 (2003).
19. Hattori Y., Ding W. X., Maitani Y., J. Controlled Release, 120, 122-130 (2007).
20. Hattori Y., Maitani Y., Cancer Gene Ther., 12, 796-809 (2005).
21. Hattori Y., Sakaguchi M., Maitani Y., Biol. Pharm. Bull., 29, 1516-1520 (2006).
22. Yamanaka K., Rocchi P., Miyake H., Fazli L., Vessella B., Zangemeister-Wittke U., Gleave M. E., Mol. Cancer Ther., 4, 1689-1698 (2005).
23. Fumoto S., Kawakami S., Ito Y., Shigeta K., Yamashita F., Hashida M., Mol. Ther., 10, 719-729 (2004).
24. Hattori Y., Kubo H., Higashiyama K., Maitani Y., J. Biomed. Nanotech., 97, 176-184 (2005).
25. Fedorov Y., Anderson E. M., Birmingham A., Reynolds A., Karpilow J., Robinson K., Leake D., Marshall W. S., Khvorova A., RNA, 12, 1188-1196 (2006).
26. Sakurai F., Inoue R., Nishino Y., Okuda A., Matsumoto O., Taga T., Yamashita F., Takakura Y., Hashida M., J. Controlled Release, 66, 255-269 (2000).
27. Ross P. C., Hui S. W., Gene Ther., 6, 651-659 (1999).
28. Takeuchi K., Ishihara M., Kawaura C., Noji M., Furuno T., Nakanishi M., FEBS Lett., 397, 207-209 (1996).
29. Turek J., Dubertret C., Jaslin G., Antonakis K., Scherman D., Pitard B., J. Gene Med., 2, 32-40 (2000).
30. Takeshita F., Ochiya T., Cancer Sci., 97, 689-696 (2006).
31. Ichim T. E., Li M., Qian H., Popov I. A., Rycerz K., Zheng X., White D., Zhong R., Min W. P., Am. J. Transplant, 4, 1227-1236 (2004).